The antibodies generated by Pfizer’s COVID-19 vaccine rise more slowly and decline more quickly than those generated by the Moderna vaccine, according to a new study from University of Virginia School of Medicine. The study also finds that older recipients of the Pfizer vaccine generated fewer antibodies than did younger recipients – but this wasn’t...
Tag: <span>Pfizer vaccine</span>
Post
Pfizer Vaccine Potentially Linked to Hearing Loss
Lindsay Kalter March 31, 2022 The World Health Organization is investigating rare instances of hearing loss and other auditory disturbances associated with COVID-19 vaccinations – primarily the Pfizer-BioNTech shots, according to a report from WHO. Of 11 billion doses given, a WHO newsletter reported 164 cases of hearing loss worldwide among people who had received Pfizer-BioNTech, Moderna or AstraZeneca shots. There...
Post
Pfizer vaccine’s protection against COVID wanes quickly in kids ages 5-11, study says
February 28, 2022 8:01 PM ET VANESSA ROMO ROB STEIN A medical staff member prepares a Pfizer-BioNTech COVID-19 vaccine at a pop-up site in New York City last October. Michael M. Santiago/Getty Images The low-dose version of the Pfizer-BioNTech COVID-19 vaccine appears to be much less effective at protecting young children against infection than the...
Post
Real-world data confirms Pfizer vaccine is safe for kids ages 5-11
New U.S. data based on nearly 9 million doses of the Pfizer-BioNTech COVID-19 vaccine delivered to kids ages 5 to 11 shows no major safety issues, according to researchers at the U.S. Centers for Disease Control and Prevention. The vaccine was first authorized for use in this age group in October. Now the new study...
Post
FDA advisers support booster dose of Pfizer vaccine in older or high-risk adults
The panel opposed, however, clearing a third shot widely for use in people older than 16 years of age.Published Sept. 17, 2021 • Shoshana DubnowAssociate Editor Ned Pagliarulo Lead Editor Jens Schlueter via Getty Images A Food and Drug Administration advisory panel on Friday unanimously supported giving a third shot of Pfizer and BioNTech’s coronavirus vaccine...
Post
No need yet to adapt Pfizer vaccine for Covid variants: BioNTech chief
Credit: Pixabay/CC0 Public Domain The first generation vaccine developed by BioNTech-Pfizer works against coronavirus variants such as the Delta strain and does not need to be modified for the moment, the chief executive of German company BioNTech said Monday. “It is quite possible that in the next six to 12 months, further variants will emerge...
Post
FDA approves emergency use of Pfizer vaccine for those aged 12 to 15
by Ernie Mundell and Robin Foster In a move that should hasten the country’s recovery from the pandemic, the U.S. Food and Drug Administration on Monday approved the emergency use of Pfizer’s two-dose coronavirus vaccine for 12- to 15-year-olds. “Today’s action allows for a younger population to be protected from COVID-19, bringing us closer to...